Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Steris PLC | 26 |
| 2 | 3M Co | 18 |
| 3 | DSM Firmenich AG | 12 |
| 4 | Massachusetts Institute of Technology | 12 |
| 5 | Merck KGaA | 9 |
| 6 | Sanofi SA | 8 |
| 7 | University of California | 8 |
| 8 | Novartis AG | 7 |
| 9 | Otsuka Holdings Co Ltd | 7 |
| 10 | Bristol Myers Squibb Co | 6 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | C12N | Microorganisms, enzymes | 174 |
| 2 | C12Y | Enzyme nomenclature (EC numbers) | 116 |
| 3 | C12P | Fermentation, enzyme processes | 112 |
| 4 | C12Q | Measuring/testing involving enzymes | 91 |
| 5 | A61K | Medicinal preparations | 81 |
| 6 | G01N | Investigating / analysing materials | 74 |
| 7 | A61P | Therapeutic activity (drug indications) | 58 |
| 8 | C07K | Peptides | 48 |
| 9 | Y10S | Cross-reference (legacy) | 25 |
| 10 | A23C | 18 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| COATINGS AND SURFACE TREATMENTS HAVING ACTIVE ENZYMES AND PEPTIDES | 2009 | 153 | |
| RAPID METHOD FOR DETERMINING EFFICACY OF A STERILIZATION CYCLE AND RAPID READ-OUT BIOLOGICAL INDICATOR | 1991 | 3M Co | 199 |
| Ubiquitin protease | 2009 | Takeda Pharmaceutical Co Ltd | 85 |
| Rapid read-out biological indicator | 1995 | 3M Co | 147 |
| 27411, a novel human PGP synthase | 2006 | Takeda Pharmaceutical Co Ltd | 92 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 4 |
| 2017 | 3 |
| 2019 | 1 |
| 2024 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | E Fischer | University of Pecs | 5 |
| 2 | Attila Almási | University of Pecs | 4 |
| 3 | Alvan C. Hengge | Utah State University | 3 |
| 4 | Pál Perjési | University of Pecs | 3 |
| 5 | Masahiro Hayashi | Tokyo University of Pharmacy and Life Sciences | 3 |
| 6 | Dong‐Hyun Kim | Kyung Hee University | 3 |
| 7 | Eung‐Chil Choi | Seoul National University | 3 |
| 8 | Takashi Mizuma | Tokyo University of Pharmacy and Life Sciences | 3 |
| 9 | Kyoichi Kobashi | Tohoku Medical and Pharmaceutical University | 3 |
| 10 | Shoji Awazu | Tokyo University of Pharmacy and Life Sciences | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Gas Chromatographic–Mass Spectrometric Analysis for Measurement of p-Cresol and Its Conjugated Metabolites in Uremic and Normal Serum | 2005 | 184 | Dialysis and Renal Disease Management |
| Probing the Origin of the Compromised Catalysis of E. coli Alkaline Phosphatase in its Promiscuous Sulfatase Reaction | 2007 | 74 | Folate and B Vitamins Research |
| An estimation of the exposure to organophosphorus pesticides through the simultaneous determination of their main metabolites in urine by liquid chromatography?tandem mass spectrometry | 2004 | 62 | Pesticide Exposure and Toxicity |
| A simple and rapid ion-pair HPLC method for simultaneous quantitation of 4-nitrophenol and its glucuronide and sulfate conjugates | 2006 | 58 | Analytical Chemistry and Chromatography |
| Purification, characterization and reaction mechanism of novel arylsulfotransferase obtained from an anaerobic bacterium of human intestine | 1986 | 54 | Enzyme Catalysis and Immobilization |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of p-Nitrophenyl sulfate?
Which organizations hold the most patents involving p-Nitrophenyl sulfate?
What research topics are associated with p-Nitrophenyl sulfate in published literature?
How has patent activity involving p-Nitrophenyl sulfate trended in recent years?
What are the primary technology classification areas for patents involving p-Nitrophenyl sulfate?